|
National Stock Number(NSN): 6505-00-735-3559 (6505007353559, 007353559)
| NIIN: |
00-735-3559 |
Item Name: |
CHLORPROMAZINE HYDROCHLORIDE TABLETS |
INC: |
09477
|
| FSC: |
6505
|
Assignment Date: |
Jan-01-1961 |
CRIT: |
X |
IIG: |
09477 |
| ISC: |
2 |
Date Standardized: |
Jul-19-1968 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
U |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9235 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00007-5074-20 |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
3 |
2 |
6 |
54 |
1 |
D |
|
|
|
|
|
NDC00182-0474-01 |
88009
|
U S DEPT OF VETERANS AFFAIRS |
H |
3 |
2 |
4 |
75 |
1 |
D |
|
|
|
|
|
NDC00781-1716-01 |
59043
|
GENEVA PHARMACEUTICALS INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
THORAZINE |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
5 |
1 |
6 |
54 |
4 |
D |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
25.000 MILLIGRAMS CHLORPROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
100.000 TABLETS |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G57V |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54|57 |
|